Hugel reports record first-half earnings driven by strong botulinum toxin growth

- H1 2026 net sales, operating profit, and net income increased 27.2%, 8.4%, and 23.5% on-year, respectively - Strategic investments to support long-term growth amid the rollout of U.S. direct sales operations - Both medical aesthetics and cosmetics fuel balanced growth across markets...